In the UK, cancer rates in 25 to 49-year-olds increased by 22 per cent in the last three decades, the biggest change in any ...

A massive undertaking to map cancer tumours is providing new insights into how the disease forms, evolves and develops resistance to treatments ...

Researchers explore the potential diagnostic utility of transcriptomic and metabolic signals in the genitourinary system.

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) recently disclosed significant clinical data from its Phase 1 expansion dose of IDE397 in patients with MTAP-deletion urothelial cancer and non-small cell lung ...

Ideaya Biosciences (IDYA) announced Phase 1 expansion data for IDE397 in methylthioadenosine phosphorylase, or MTAP-deletion urothelial cancer, ...

Researchers have shown for the first time that it is possible for a specially-designed ‘mini-protein’ to deliver a radiation ...

Around 8% of patients with advanced metastatic bladder cancer survive for five years or more. In healthy, normal cells, Fibroblast ... can take the form of small changes, called mutations, or ...

“In this multicenter randomized clinical trial, we did not observe a benefit of prophylactic tranexamic acid in reducing red blood cell transfusion in patients undergoing open radical cystectomy for ...

Around 8% of patients with advanced metastatic bladder cancer survive for five years or more [2]. In healthy, normal cells ... can take the form of small changes, called mutations, or larger ...

Researchers have shown for the first time that it is possible for a specially-designed ‘mini-protein’ to deliver a radiation dose directly to tumour cells expressing a protein on their cell surfaces ...

Nine patients had metastatic bladder cancer, three had metastatic breast cancer, three had cervical cancer, two had colorectal cancer and three had non-small cell lung cancer. They gave the ...

Around 8% of patients with advanced metastatic bladder cancer survive for five years or more. In healthy, normal cells, Fibroblast ... can take the form of small changes, called mutations, or ...